REB Review Fee

The fee for ethical review of industry sponsored studies is $3,500 and applies only to research that receives its funding from an industry sponsor (e.g. pharmaceutical/medical devices company or an agent thereof). The fee covers the submission of the initial request for ethical review, subsequent amendment and renewal applications, as well as the submission of serious and unexpected adverse event reports in the case of clinical trials.

Payment of the required fee, or a letter stating that the fee will follow and by when, must accompany the Application for Research Ethics Review for all industry-sponsored research. It is the responsibility of the Principal Investigator to ensure that their sponsor is aware of this requirement and to submit the cheque or letter at the time of the submission to the REB. The REB will review the research only if the fee or a letter accompanies the application.

Waiver Criteria

The fee is waived for:

  • Studies receiving a grant-in-aid (normally an investigator-initiated study with partial funding-e.g. supply of drugs or devices or a very limited amount of funding from an industry sponsor);
  • Studies that are funded by not-for-profit agencies;
  • Studies that receive internal grants either from RQHR-affiliated institutions (including self-funded);
  • Studies funded by CIHR, NSERC, CHSRF, and NIH (including NIH Institutes), and;
  • Studies without funding.

Submitting the Fee

Cheques and requests for invoices sent to the REB office AFTER the submission of the initial application must include a memo with the exact title of the research study and the Principal Investigator’s name.

Cheques should be addressed and sent to:

Regina Qu’Appelle Health Region
Regina Qu’Appelle Health Region Research Ethics Board
Research and Health Information Services
2180-23rd Avenue. Room M-704
Regina, SK S4S 0A5

Requirements for Fee Refund

The fee will be totally refunded if the associated research study is withdrawn prior to review. $500.00 of the fee amount will be non-refundable if the associated research study is withdrawn after the review.